Cspc Megalith Biopharmaceutical Co.,ltd.

This study tests two experimental drugs, SYS6010 and Enlonstobart, in people with head and neck cancer that has come back or spread. The goal is to see if the combination can shrink tumors and improve survival. About 70 adults who have not had prior systemic treatment will take p…

This study tests a new drug called SYS6010 against standard chemotherapy for people with a specific type of advanced lung cancer (EGFR-mutated non-small cell lung cancer) that has stopped responding to targeted pills. About 380 adults aged 18-75 will be randomly assigned to recei…

This study is testing a new drug called SYS6043 in people with advanced or metastatic solid tumors that have not improved with standard treatments. The drug is designed to target and attack cancer cells while limiting harm to healthy cells. The goal is to find the safest dose and…